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Abstract 18 
 19 
Objective: To explore indirect evidence of reporting biases by examining the distribution of P-20 
values/z-scores reported in published medical articles, and to compare P-values/z-scores 21 
distributions across different contexts. 22 
Methods: We selected a random sample (n=1500) of articles published in PubMed in March 23 
2014, and included articles that reported sufficient details of the results of inferential 24 
statistics. Additionally, we extracted information on study type, design, medical discipline and 25 
P-values/z-scores for the first-reported outcome and primary outcome (if specified) from 26 
each article.  27 
Results: Out of the 1500 randomly selected records, 758 (50.5%) were included. We retrieved 28 
or calculated 758 P-values/z-scores for first-reported outcomes and 389 for primary 29 
outcomes (specified in only 51% of included studies). The first-reported and the primary 30 
outcome differed in 28% (110/389) of the included studies. The distributions of P-values/z-31 
scores for first-reported outcomes and primary outcomes showed a notable discontinuity at 32 
the common threshold of statistical significance (P-value=0.05/z-score=1.96). A caliper test 33 
showed an imbalance in the z-scores around the common significance threshold using 5% and 34 
10% caliper sizes for the first reported outcomes as well as primary outcomes. We also found 35 
marked discontinuities in the distributions of z-scores across various medical discplines, study 36 
designs and types. 37 
Conclusions: Reporting biases are still common in medical research. We discuss its 38 
implications, strategies to detect it and recommended practices to avoid them. 39 
 40 
Keywords: bias, p-curve, p-hacking, methodology, reporting bias, publication bias 41 
Work count: Abstract: 219, Main text: 2944, Tables: 2, Figures: 4, References: 40, Appendices: 42 
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  45 
What is new? 
Key finding 
• There are discontinuities of the distribution of p-values/z-values at the 
typical thresholds of statistical significance that may provide indirect 
insights on reporting bias 
• Similar results were observed across various study designs and types.  
 
What this study adds to what is known?  
• Notable peaks in the distributions at common thresholds of statistical 
significant are consistent with either suppression of non-statistically 
significant results or ‘manipulation’ of reported findings to reach 
statistical significance. 
• The outcome that is reported earliest in an article is more prone to this 
phenomenon than the primary outcome. 
 
 
What is the implication, and what should change now?  
• The present investigation underpin the importance of the efforts and 
initiatives to tackle the mechanisms causing reporting biases (e.g. 
registration of studies, protocols and statistical analysis). 
• Researchers should continue to be encouraged to emphasize confidence 
intervals and effect sizes, rather than P-values, in the interpretation of 
results. 
• There is a need for advocating the importance of replication, as well as 
the benefits of complete publication of research findings to reduce the 
prevalence of reporting biases in scientific literature 
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Introduction 46 
Complete publication of study results is essential to allow healthcare professionals and policy 47 
makers to make informed decisions. However, selective or distorted reporting is frequent in 48 
medical research.[1] Reporting biases arise if dissemination of research findings is influenced 49 
by the nature of the results. If undetected, reporting biases can lead to inaccurate conclusions 50 
and inappropriate decisions about health care and resource allocation, with potentially 51 
serious implications.[2] Failure to publish research findings honestly is unethical and a form of 52 
research misconduct.[3, 4] Furthermore, research inaccessibility leads to waste of limited 53 
resources, unnecessary duplication, and loss of trust in scientific integrity.[5] 54 
 55 
Reporting biases may impact scientific reports in different ways.[6-9] First, a whole study may 56 
be suppressed, or harder to find, or published with delay, if its results are not considered to 57 
be interesting. The label ‘publication bias’ is typically used to refer to this phenomenon.[10] 58 
Publication bias is the form of reporting bias that has been most extensively discussed in the 59 
literature over the last 60 years. [11-13] Second, results within a report of a study may be 60 
biased if the authors report the most interesting findings. For example, they may report the 61 
finding with smallest P-value or largest effect estimate after performing several analyses on 62 
the same outcome. Several terms have been coined to refer to such practice, including 63 
selective analysis reporting, data dredging and p-hacking.[14] Alternatively, some outcomes 64 
that were measured and analysed may be missing if the authors did not consider the results 65 
to be interesting.  66 
 67 
Although these reporting biases are likely to have been always present in the dissemination of 68 
research findings, more attention has been drawn to them recently due to the widespread 69 
use of systematic reviews. The validity of conclusions drawn from systematic reviews, 70 
intended to summarize the state of the art in a scientific area, is threatened if published 71 
results are not representative of the population of all conducted studies and analyses. Meta-72 
analysis provides researchers with several graphical methods and statistical tests to assess the 73 
possible presence of reporting biases.[6, 10, 13, 15] The exponential growth of published 74 
meta-analyses, many of them including some assessment of reporting biases, is likely to have 75 
increased the concern of incomplete publication of results as an ubiquitous problem in the 76 
scientific literature.[8]  77 
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 78 
Evidence of reporting biases can be direct or indirect. Direct evidence includes tracking of 79 
cohorts of registered studies or conference proceeding abstracts and comparing the results of 80 
published and unpublished findings. For instance, studies have provided empirical evidence 81 
that studies with significant or positive results were more likely to be published, or more likely 82 
to be published earlier, than those with non-significant or unimportant results. [5, 8] Direct 83 
evidence may also come from the acknowledgement of bias by those involved in the 84 
publication process, such as researchers, referees and editors.[16] 85 
 86 
Indirect sources of evidence of reporting biases include the observation of a 87 
disproportionately high percentage of statistically significant findings in the published 88 
literature, as well as notable discontinuities in the P-value/z-score distribution curve just 89 
above the main significance thresholds (p=0.05/z-score=1.96). Several papers have been 90 
published illustrating similar approaches in psychology, sociology and natural science.[14, 17-91 
19] Here we aim to explore indirect evidence of reporting biases by examining the empirical 92 
distribution of P-values/z-scores reported in a large set of medical research studies, and to 93 
compare this distribution across different contexts. 94 
 95 
  96 
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Methods 97 
Study eligibility and selection 98 
We conducted a descriptive cross-sectional survey of peer-reviewed, published, medical 99 
research articles. We sought original, primary and quantitative research articles, and searched 100 
the PubMed database using a simple search strategy that would identify most of these 101 
(Appendix 1). We restricted the search to articles published in March 2014, and selected a 102 
random sample of 1500 of the identified articles. To be included in the analyses, articles had 103 
to be written in English and had to involve only human participants. Articles had to include 104 
inferential statistics that investigated the efficacy or side effects of a medical or surgical 105 
intervention; or investigating risk factors, exposures or prognostic factors (epidemiological 106 
associations). We considered a wide range of study designs including randomized clinical 107 
trials, controlled clinical trials, before-after trials, cohort studies, case-control studies and 108 
cross-sectional studies, and we considered a wide range of estimates including differences in 109 
means, risk ratios, odds ratios, hazard ratios, correlations and regression coefficients. We 110 
included only articles that either reported the P-value or provided sufficient information to 111 
calculate a P-value for either the first reported or the primary outcome. We excluded 112 
duplicate reports of the same study as well as inaccessible full-text articles (e.g. published 113 
abstracts without full articles, or study protocols). 114 
 115 
Data screening and extraction 116 
We developed a standardised data extraction form, which was pilot-tested by all members of 117 
the research team.  We extracted data based on the first reported outcome in the abstract 118 
(preferentially) or in the results section. For each included article, we extracted the following 119 
information:  120 
• Author list and citation details. 121 
• Medical speciality: we used the categories suggested by Davey et al.[20] 122 
• Study type: therapeutic/intervention, prognostic, aetiological/risk factor. 123 
• Study design: we used the classification used by Grimes et al:[21] randomized 124 
controlled trial (RCT), non-RCT, cohort, case-control, cross-sectional. 125 
• Sample size: total sample size used in the analysis which yielded the P-value. 126 
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• Whether the primary outcome was specified (Yes/No) and whether it was the same as 127 
the first reported outcome (Yes/No/Unclear). 128 
• 2-sided P-value, or information sufficient to calculate it, for the first reported outcome 129 
and for the primary outcome (if specified). We used the following hierarchy to 130 
determine each P-value, where only one of the following types of information was 131 
required: 132 
1. Exact 2-sided P-value: from the hypothesis test. 133 
2. Effect estimate with standard error or confidence limits: We used methods 134 
described by Altman and Bland to calculate P-values[22] from these measures. 135 
3. Test statistics: Z, chi-squared, t or F statistic, with degrees of freedom if 136 
applicable. 137 
4. For two-group designs reporting continuous outcome data: sample size, mean 138 
and standard deviation (or standard error) for each group. 139 
5. For studies reporting dichotomous outcome data: contingency table (e.g. 2×2 140 
table). 141 
Where a specified primary outcome differed from the first reported one, we implemented 142 
the same hierarchy to extract a P-value for each of the two outcomes. 143 
 144 
Data analysis 145 
As a first step, we transformed the two-sided p-values into z-scores, and used the latter as 146 
our main dependent variable. We plotted the distribution of z-scores across all included 147 
studied, both for first reported outcomes and for primary outcomes, using histograms. In the 148 
absence of any bias and if all effects are truly null, these z-scores would be uniformly 149 
distributed. We repeated these plots with subsets of the studies to explore the distributions 150 
of z-scores stratified by medical specialty, study design and study type. Moreover, we used 151 
the caliper test described by Gerber and Malhotra  to explore the existence of discontinuities 152 
in the distribution of z-scores around the critical value of 1.96[19]. With regards to p-values, 153 
we compared the frequency of values in equal sized intervals just below and just above the 154 
threshold values commonly used for statistical significance (0.01 and 0.05), using a chi-155 
squared test. We performed all analyses using the R statistical software (version 3.2.3).[23] 156 
  157 
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Results 158 
Description of included studies 159 
Figure 1 displays the study selection process in a flow chart. Of the 1500 randomly selected 160 
articles, we included 758 (50.5%). Among these included articles, 422 (56%) described 161 
therapeutic/intervention studies, 207 (27%) were aetiological/risk factor studies, and 129 162 
(17%) were prognostic studies. With regards to study design, 264 (35%) were RCTs, 53 (7%) 163 
were non-RCTs, 145 (19%) were cross-sectional, 238 (32%) were cohort and 55 (7%) were 164 
case-control studies.  165 
The medical disciplines of the included articles were cancer (105; 14%), cardiovascular (116; 166 
15%), central nervous system/musculoskeletal (97; 13%), digestive, endocrine, nutritional and 167 
metabolic (98; 13%), gynaecology/pregnancy/birth (58; 8%), infectious (44; 6%), mental 168 
health/behavioural (75; 10%), urogenital (33; 4%), respiratory (21; 3%) and other disorders 169 
(111; 14%). The sample size of all included studies ranged from 6 to 375,888, with a median 170 
of 142 participants (range 55-525; IQR=470).  171 
Out of the 264 included RCTs, the primary outcome was specified in 190 (72%). The primary 172 
outcome was also the first reported outcome in 143 (75%) studies, while it was not the first 173 
reported outcome in 45 (24%) and unclear in 2 (1%). In studies other than RCTs, the primary 174 
outcome was specified only in 199 out of 494 included studies (40%). The primary outcome 175 
was also the first reported outcome in 133 (67%) studies, while it was not the first reported 176 
outcome in 65 (33%) and unclear in one study. 177 
The 742 excluded articles comprised 245 (33%) with only descriptive statistics, 144 (19%) with 178 
no original data, 121 (16%) with inaccessible full texts, 84 (11%) that were diagnostic or cost-179 
analysis studies, 58 (8%) without sufficient information to extract or calculate a P-value, 48 180 
(7%) with non-human research participants and 42 (6%) that were qualitative. 181 
 182 
Empirical distribution of z-scores and p-values 183 
We retrieved 758 results for first reported outcomes, with a median P-value of 0.011[0.0006 - 184 
0.45] (z-score: 2.29[3.24-0.126]). Figure 2 shows the distribution of z-scores for first reported 185 
outcomes and primary outcomes, with dashed vertical lines for the common threshold of p = 186 
0.05/z = 1.96 for statistical significance. In both distributions, there is a  clear majority of z-187 
scores above 1.96. Of particular note is the dramatic spike in the frequency of z-scores just 188 
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over the significance threshold z-score of 1.96 (P-value = 0.05). The results of the caliper tests 189 
using 5% and 10% caliper sizes for the first reported outcomes as well as primary outcomes 190 
showed a notable imbalance in the numbers of findings around the common significance 191 
threshold of 1.96 (P-value = 0.05), which is evident across the two caliper sizes (5% and 10%) 192 
in both first reported outcomes and primary outcomes (Table 1).  193 
Table 2 shows that the majority of the retrieved P-values (both for first reported and primary 194 
outcomes) were smaller than common significance thresholds (0.05 and 0.01) with a total of 195 
592 (78%) P-values of first reported outcomes were equal to or smaller than 0.05, and 376 196 
(50%) were also equal to or smaller than 0.01. 197 
The distribution of P-values reported in included studies for the first reported outcomes 198 
compared with the primary outcomes and grouped by study design (RCTs vs. studies other 199 
than RCTs). It shows that P-values more likely to be significant for the first reported outcomes 200 
than for the primary outcomes in RCTs only (p-value = 0.02391) (Table 3). 201 
 202 
Stratified analyses 203 
Figure 3 shows the histograms of z-scores for first reported outcomes stratified by medical 204 
speciality, annotated by median sample sizes within specialties. All figures reflect the same 205 
pattern of a majority of z-scores over the threshold of statistical significance, but the 206 
distributions appear less skewed in some of the disciplines with larger average sample sizes, 207 
namely infectious diseases (n=28; 63.6% of z-scores above 1.96), urogenital (n=21;  63.6%) 208 
and cancer (n=75; 71.4%). The most extreme patterns appeared in the area of respiratory 209 
diseases (n=19; 90.5% of z-scores above 1.96), cardiovascular (n=97; 83.6%) and central 210 
nervous system or musculoskeletal disorders (n= 78; 80.4%). Similar trends were observed in 211 
the histograms of z-scores for primary outcomes stratified by medical speciality, which are 212 
provided in Appendix 2. 213 
 214 
Histograms of z-scores for first reported outcomes did not show major differences in the 215 
distribution according to study design (Figure 4). Likewise, we obtained similar histograms 216 
when exploring the distributions of z-scores for first reported outcomes stratified by study 217 
type, and also when plotting the distributions of z-scores for primary outcomes stratified by 218 
study design or by study type (Appendix 2). 219 
  220 
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Discussion 221 
Our distributions of reported P-values/z-scores from medical research studies show notable 222 
peaks (or discontinuities) in the distributions at the common threshold of statistical 223 
significance (z-score = 1.96/p = 0.05) that may provide indirect insights on reporting bias. The 224 
outcome that is reported earliest in an article is more prone to this phenomenon than the 225 
primary outcome. Only about half of the included articles specified the primary outcome, and 226 
in 28% of the articles the first reported outcome was not the primary outcome. Similar 227 
patterns were observed across various medical discplines, study designs and types. 228 
 229 
Strengths of our study include use of a large random sample of 1500 articles recently 230 
published, of which 758 contributed to the analysis. We also implemented manual data 231 
extraction from the articles; provided a breakdown by medical disciplines, study type and 232 
study design; and computed z-scores/P-values when they were not reported directly. 233 
However, we were unable to retrieve all of the articles listed in our random sample (see 234 
Figure 1). We are unable to draw any conclusions about whether the observed distribution is 235 
due to data manipulation (‘p-hacking’) or genuine effects, because as Bruns and Ioannidis 236 
suggested[24], p-curves may neither identify genuine effects nor p-hacking in observational 237 
research.   238 
 239 
The presence of reporting biases has been claimed repeatedly in the medical literature,[1, 4, 240 
8] and in other areas as diverse as cognitive sciences,[17, 25] biology,[26] educational 241 
research,[27] political sciences,[28] and management research.[7] Although definitions of 242 
reporting biases and strategies to explore vary, the conclusions and implications for 243 
researchers are similar across disciplines. Previous studies have investigated empirical 244 
distributions of published P-values. A study of abstracts in PubMed reported an extremely 245 
skewed distribution of P-values, with a substantially higher proportion of P-values below 0.05 246 
in non-randomized studies compared to randomized trials.[29] In a review of meta-analyses, 247 
Ioannidis and Trikalinos also concluded that significant P-values were overrepresented [30]. In 248 
psychology, some studies also explored the P-value distribution and showed an inordinately 249 
high number of P-values just below 0.05.[17, 31]  250 
 251 
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It is good practice to specify the primary outcome before performing the statistical analysis of 252 
a clinical trial.[9] In our survey, we found that 72% of the RCTs vs. 40% of studies other than 253 
RCTs specified the primary outcome in their reports. Moreover, the specified primary 254 
outcome and first reported outcome differed in 24% of the included RCTs compared with 255 
33% in the included studies other than RCTs. In addition, we found that the proportion of 256 
significant P-values is higher in first reported outcomes compared with primary outcomes in 257 
RCTs. This is consistent with observations in epidemiological research comparing primary 258 
outcomes stated in the protocol with those declared in the final report.[32, 33]  259 
 260 
Reporting biases are a prevalent and complex phenomenon across most scientific areas, 261 
including epidemiology. Our survey adds to the evidence that statistically significant findings 262 
are still overrepresented in current medical research. The phenomenon limits the validity of 263 
conclusions drawn from the published literature, and has led to expressions of major 264 
concerns and disbelief about the usefulness of scientific evidence.[34, 35] It is important that 265 
techniques are used to assess the potential extent of these threats to published evidence, 266 
whether in the context of a systematic review or otherwise. Meta-analysis methods provide 267 
some of the most direct tools for this, although have major limitations. 268 
 269 
Efforts should be increased to tackle the mechanisms causing reporting biases. Initiatives to 270 
facilitate registration of studies, protocols and statistical analysis plans are key in this regard. 271 
The common practice of interpreting results based on significance tests is likely to have an 272 
important role, and researchers should continue to be encouraged to emphasize confidence 273 
intervals and effect sizes, rather than P-values, in the interpretation of results.[22, 36, 37] 274 
Furthermore, the pressure imposed on researchers to produce scientific publications on a 275 
regular basis, coupled with the increasing emphasis on research impact (including journal 276 
impact factor), may lead them to dismiss scientific findings for publication if their results are 277 
insufficiently innovative or not in agreement with the dominant paradigm. This risks a 278 
prioritization of aspects other than rigor and scientific quality when presenting their findings 279 
in scientific reports.[38] A new framework in which the importance of replication, as well as 280 
the benefits of complete publication of research findings, has been advocated as a promising 281 
approach to reduce the prevalence of reporting biases in scientific literature.[25, 39, 40] 282 
 283 
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Tables  382 
Table 1. Caliper test for reporting biases in first reported outcomes and primary outcomes. 383 
 384 
Under caliper: number of z-scores that are between 0 and X% smaller than 1.96, with X being the caliper size; over caliper: 385 
number of z-scores that are between 0 and X% greater than 1.96; P-value: p-value from a one-tailed binomial test 386 
  387 
 5% caliper 10% caliper 
Under 
caliper 
Over 
caliper 
P-value Under 
caliper 
Over 
caliper 
P-value 
First reported 
outcomes 
17 44 <.001 24 60 <.001 
Primary 
outcomes 
9 23 0.010 13 35 0.001 
17 
 
Table 2. Distribution of P-values for all first reported outcomes and primary outcomes. 388 
 389 
 390 
 391 
 392 
 393 
 394 
 395 
The distribution of the P-values for the first reported outcomes compared to 396 
primary outcomes was performed by the analysis of frequencies (χ2
2 = 10.412; p-397 
value = 0.005).  398 
 399 
 400 
  401 
 P-values 
>0.05 
P-values 
0.05 & >0.01 
P-values 
0.01 
First reported 
outcomes 
166 (21.9%) 216 (28.5%) 376 (49.6%) 
Primary 
outcomes 
118 (30.6%) 101 (26.2%) 167 (43.3%) 
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 402 
Table 3. Distribution of P-values for all first reported outcomes and primary outcome 403 
grouped by the study design (RCTs vs. studies other than RCTs). 404 
 405 
 406 
The distribution of the P-values for the first reported outcomes compared to primary outcomes was performed by the 407 
analysis of frequencies in included a RCTs (𝜒2
2 = 7.4666; p-value = 0.0239); b Studies other than RCTs (𝜒2
2 = 1.2052; p-value = 408 
0.5474).  409 
 410 
 411 
 412 
 413 
  414 
 P-values from RCTs P-values from studies other than RCTs 
 >0.05 0.05 & 
>0.01 
0.01 >0.05 0.05 & 
>0.01 
0.01 
First reported 
outcomesa 
71  
(26.9%) 
77  
(29.2%) 
116 
(43.9%) 
96  
(19.4%) 
139 
(28.1%) 
259 
(52.4%) 
Primary 
outcomesb 
73  
(38.6%) 
51  
(27.0%) 
65  
(34.4%) 
45  
(22.8%) 
50  
(25.4%) 
102 
(51.8%) 
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 415 
Figures 416 
 417 
 418 
 419 
Figure 1. Flow chart for identification of relevant articles from a random sample of records 420 
in PubMed  421 
 422 
423 
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 424 
Figure 2. Histograms of z-scores across all articles 425 
These figures display z-scores in absolute value, with the bottom x-axis indicating the 426 
corresponding p-value in a two-tailed test; the red dashed line represents the common 427 
threshold of p = 0.05 for significance tests. 428 
  429 
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 430 
 431 
Figure 3. Histograms of z-scores for first reported outcomes, stratified by medical 432 
discipline.  433 
These figures display z-scores in absolute value, with the bottom x-axis indicating the 434 
corresponding p-value in a two-tailed test; the dashed line represents the common 435 
threshold of p = 0.05 for significance tests; k: number of studies; N: sample size. 436 
  437 
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 438 
 439 
Figure 4. Histograms of z-scores for first reported outcomes, stratified by study design 440 
These figures display z-scores in absolute value, with the bottom x-axis indicating the 441 
corresponding p-value in a two-tailed test; the dashed line represents the common 442 
threshold of p = 0.05 for significance tests; k: number of studies. 443 
 444 
  445 
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Appendices 446 
Appendix 1. Search strategy for PubMed/Medline 447 
1. "2014/03/01"[Date - Publication] : "2014/03/31"[Date - Publication] 448 
2. Clinical Trial[ptyp]  449 
3. Clinical Trial, Phase III[ptyp]  450 
4. Comparative Study[ptyp]  451 
5. Controlled Clinical Trial[ptyp]  452 
6. Multicenter Study[ptyp]  453 
7. Observational Study[ptyp]  454 
8. Randomized Controlled Trial[ptyp]  455 
9. Pragmatic Clinical Trial[ptyp]  456 
10. Twin Study[ptyp] 457 
11. 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 458 
12. Humans[Mesh]  459 
13. English[lang] 460 
14. 1 AND 11 AND 12 AND 13 461 
  462 
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Appendix 2. Supplementary figures 463 
 464 
 465 
Figure S1. Histograms of z-scores for primary outcomes, stratified by medical discipline 466 
These figures display z-scores in absolute value, with the bottom x-axis indicating the 467 
corresponding p-value in a two-tailed test; the dashed line represents the common 468 
threshold of p = 0.05 for significance tests; k: number of studies; N: sample size. 469 
  470 
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 471 
 472 
Figure S2. Histograms of z-scores for first reported outcomes, stratified by study type 473 
These figures display z-scores in absolute value, with the bottom x-axis indicating the 474 
corresponding p-value in a two-tailed test; the dashed line represents the common 475 
threshold of p = 0.05 for significance tests; k: number of studies. 476 
  477 
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 478 
 479 
Figure S3. Histograms of z-scores for primary outcomes, stratified by the study design 480 
These figures display z-scores in absolute value, with the bottom x-axis indicating the 481 
corresponding p-value in a two-tailed test; the dashed line represents the common 482 
threshold of p = 0.05 for significance tests; k: number of studies. 483 
  484 
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 485 
 486 
Figure S4. Histograms of z-scores for primary outcomes, stratified by the study type 487 
These figures display z-scores in absolute value, with the bottom x-axis indicating the 488 
corresponding p-value in a two-tailed test; the dashed line represents the common 489 
threshold of p = 0.05 for significance tests; k: number of studies. 490 
 491 
